Biocon on Friday said it has received the establishment inspection
report (EIR) from US health regulator for the post-approval and good
manufacturing practice (GMP) inspection of its small molecules
manufacturing facility in Bengaluru.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/biocon-gets-eir-from-usfda-for-manufacturing-facility-in-bengaluru/articleshow/74725567.cms
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment